Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Advanced Cancer 1

Interventions

apatinib 2 nimotuzumab 1 fluorapacin 1 Standard of Care 1 Neoadjuvant Therapy 1 Decision Support Techniques 1 Control Groups 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Advanced Cancer × fluorapacin × Clear all

NCT01361529 2011-05-27

Safety Study of FLP Injection to Treat Tumor Patients

Acea Bio (Hangzhou) Co., Ltd.

Phase 1 Unknown

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡